Matthew Reeves MD, MPH, FACOG

Matthew Reeves, MD, MPH, FACOG, is the Chief Executive Officer and founder of the DuPont Clinic. With the team at the DuPont Clinic, Dr. Reeves has worked to re-envision the patient experience, create a new patient flow without a waiting room, develop new shortened protocols for later abortion, improve pain control techniques, and develop improved gynecologic instruments. Dr. Reeves maintains hospital privileges at Sibley Memorial Hospital, George Washington University Hospital, and MedStar Washington Hospital Center. In addition to his role at DuPont Clinic, Dr. Reeves holds appointments as an Adjunct Clinical Associate Professor of Obstetrics and Gynecology at Stanford University School of Medicine and as an Adjunct Associate Professor at the Johns Hopkins Bloomberg School of Public Health.

Dr. Reeves also serves on the board of directors of DKT International, a social marketing organization that provided over 44 million couple-years of contraception in over 25 countries and is now the sole distributor for Ipas aspirators and Sino-Implant II. Dr. Reeves also is a member of the Editorial Board of BMJ Sexual & Reproductive Health. Previously, Dr. Reeves served as the first Medical Director of the National Abortion Federation. In that role, he was responsible for the NAF Clinical Policy Guidelines and worked to improve the quality of abortion care across North and South America. From 2010 to 2014, Dr. Reeves was the Chief Medical Officer of WomenCare Global, where his work focused on expanding the use of manual uterine aspiration and introducing mifepristone and levonorgestrel implants to new markets globally. He also served as a Medical Officer at CONRAD at Eastern Virginia Medical School, focusing on early-stage development of new contraceptive and HIV-prevention products. Before moving to Washington, DC, in 2009, he was on faculty at the University of Pittsburgh School of Medicine and an attending physician at Magee-Womens Hospital working in both the Ultrasound and Gynecologic Specialties divisions. Dr. Reeves has researched gynecologic ultrasound, contraceptive development, early-phase clinical trials of HIV-prevention products, cost-effectiveness, and provision of reproductive health services globally. Dr. Reeves has conducted training on clinical ultrasound, intrauterine and subdermal contraception, uterine aspiration, and mifepristone in English and Spanish in North and South America, Africa, Europe, and Asia.

Dr. Reeves attended Harvard Medical School and completed a residency in obstetrics and gynecology at the University of California, San Francisco (UCSF). Following his residency, Dr. Reeves completed a Fellowship in Clinical Ultrasound at the UCSF Department of Radiology followed by a Fellowship in Family Planning and Contraceptive Research at the University of Pittsburgh. Dr. Reeves has been a Fellow of the American College of Obstetricians & Gynecologists since 2008 and a Fellow of the Society of Family Planning, also since 2008. He is also an active member of the American Institute of Ultrasound in Medicine and the International Society of Ultrasound in Obstetrics and Gynecology.